GERN
Geron Corporation · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +10.0% ·
Aktienfluss -3.0% ·
neue Nettopositionen +9.1%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 91 | +1 | 281.46M | $360.40M | +7 | −6 |
| Q1 2026 | 93 | -3 | 271.64M | $404.62M | +7 | −10 |
| Q4 2025 | 95 | -3 | 246.07M | $324.82M | — | −3 |
| Q3 2025 | 17 | 0 | 193.54M | $265.15M | +2 | −2 |
| Q2 2025 | 14 | +1 | 162.89M | $229.67M | +1 | — |
| Q1 2025 | 10 | -1 | 76.28M | $121.30M | — | −1 |
| Q4 2024 | 11 | +1 | 96.17M | $340.44M | +2 | −1 |
| Q3 2024 | 9 | 0 | 71.98M | $326.79M | +2 | −2 |
| Q2 2024 | 9 | — | 67.08M | $284.41M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passiv) | 27.16M | — | $96.14M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Adage Capital Partners ✦ | 21.80M | -24.5% | $77.17M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 13.51M | +6.7% | $47.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 13.51M | +6.7% | $47.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 13.51M | +6.7% | $47.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 13.51M | +6.7% | $47.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 13.51M | +6.7% | $47.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 13.51M | +6.7% | $47.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passiv) | 13.14M | +0.6% | $46.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passiv) | 13.14M | +0.6% | $46.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 7.03M | +70.7% | $24.90M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 4.18M | -10.7% | $14.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 4.18M | -10.7% | $14.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 3.94M | -44.0% | $13.95M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 3.94M | -44.0% | $13.95M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Marshall Wace ✦ | 2.20M | +73.1% | $7.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 2.20M | +73.1% | $7.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Marshall Wace ✦ | 2.20M | +73.1% | $7.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 1.49M | Neu | $5.27M | 0.0% | New | 1 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 1.45M | Neu | $5.14M | 0.0% | New | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 251.76K | +11.0% | $891,234 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 251.76K | +11.0% | $891,234 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 251.76K | +11.0% | $891,234 | 0.0% | ▲ Add | 3 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Point72 Asset Management | $5.27M | 0.0% |
| Renaissance Technologies | $5.14M | 0.0% |
Ausgestiegen
| D. E. Shaw & Co. | $145,239 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 253 Inhaber, 492.17M Anteile, $730.64M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.